Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Whole Shine Medical Technology Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Ning Ding

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	2.6yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	4.1yrs

Son yönetim güncellemeleri

Recent updates

Further Upside For Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Shares Could Introduce Price Risks After 36% Bounce

Oct 01

Whole Shine Medical Technology (SZSE:002622) Is Experiencing Growth In Returns On Capital

Aug 26

Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 21

Not Many Are Piling Into Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock Yet As It Plummets 27%

Jun 05

Why We're Not Concerned Yet About Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) 28% Share Price Plunge

Apr 21

Shareholders Should Be Pleased With Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) Price

Mar 05

CEO

Ning Ding (41 yo)

2.6yrs

Görev süresi

CN¥533,000

Tazminat

Mr. Ning Ding serves as General Manager of Whole Shine Medical Technology Co., Ltd. since March 04, 2022.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zhuang Miao	Chairman of the Supervisory Board	4.1yrs	Veri yok	Veri yok
Lu Lu	Chairman	5.6yrs	CN¥1.20m	Veri yok
Zhanbin Niu	Non-Independent Director	4.1yrs	Veri yok	Veri yok
Yuting Tuo	Non-Independent Director	4.1yrs	Veri yok	Veri yok
Guigang Pan	Non-Independent Director	4.1yrs	Veri yok	Veri yok
Xin Qiu	Independent Director	4.1yrs	CN¥126.00k	Veri yok
Lin Jiang	Independent Director	4.1yrs	CN¥126.00k	Veri yok
Yawei Chen	Independent Director	4.1yrs	CN¥126.00k	Veri yok
Gujia Zhu	Director	no data	Veri yok	Veri yok

4.1yrs

Ortalama Görev Süresi

42.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 002622 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.1 yıldır).

Whole Shine Medical Technology Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 20, 2024

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 23, 2023

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Further Upside For Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Shares Could Introduce Price Risks After 36% Bounce

Whole Shine Medical Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Share price stability

Whole Shine Medical Technology (SZSE:002622) Is Experiencing Growth In Returns On Capital

Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Whole Shine Medical Technology Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

New minor risk - Share price stability

Not Many Are Piling Into Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock Yet As It Plummets 27%

New minor risk - Financial data availability

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 20, 2024

Why We're Not Concerned Yet About Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) 28% Share Price Plunge

New minor risk - Share price stability

Whole Shine Medical Technology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Now 23% undervalued after recent price drop

Shareholders Should Be Pleased With Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) Price

Now 28% undervalued after recent price drop

Now 26% undervalued after recent price drop

Whole Shine Medical Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.02 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.011 (vs CN¥0.006 loss in 2Q 2022)

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 23, 2023

First quarter 2023 earnings released: CN¥0.001 loss per share (vs CN¥0.03 loss in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.008 loss in 3Q 2021)

Rongyu Group Co., Ltd. announced that it expects to receive CNY 652 million in funding

Second quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.015 profit in 2Q 2021)

First quarter 2022 earnings released: CN¥0.03 loss per share (vs CN¥0.004 loss in 1Q 2021)

High number of new and inexperienced directors

Third quarter 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.006 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.015 (vs CN¥0.038 loss in 2Q 2020)

Rongyu Group Co., Ltd. (SZSE:002622) signed a framework agreement to acquire 52% stake in Guangzhou Delun Medical Investment Co., Ltd. from Gongqingcheng Delun Medical Investment Management Partnership (Limited Partnership).

Rongyu to Buy 67% Stake in Healthcare Firm for Up to 441.5 Mln Yuan

Full year 2020 earnings released: CN¥0.34 loss per share (vs CN¥0.009 profit in FY 2019)

New 90-day low: CN¥2.13

New 90-day low: CN¥2.79

New 90-day high: CN¥3.63

Third quarter earnings released

New 90-day low: CN¥3.03

First half earnings released

Rongyu Group Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş